These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 2146989)
21. Interleukin 2 induction of pore-forming protein gene expression in human peripheral blood CD8+ T cells. Smyth MJ; Ortaldo JR; Shinkai Y; Yagita H; Nakata M; Okumura K; Young HA J Exp Med; 1990 Apr; 171(4):1269-81. PubMed ID: 1691263 [TBL] [Abstract][Full Text] [Related]
22. Activation of human T cells obtained pre- and post-interleukin-2 (IL-2) therapy by anti-CD3 monoclonal antibody plus IL-2: implications for combined in vivo treatment. Weil-Hillman G; Schell K; Segal DM; Hank JA; Sosman JA; Sondel PM J Immunother (1991); 1991 Aug; 10(4):267-77. PubMed ID: 1834166 [TBL] [Abstract][Full Text] [Related]
23. FcR-mediated crosslinking of Ta1 (CDw26) induces human T lymphocyte activation. Dang NH; Hafler DA; Schlossman SF; Breitmeyer JB Cell Immunol; 1990 Jan; 125(1):42-57. PubMed ID: 2152856 [TBL] [Abstract][Full Text] [Related]
24. Inhibitory effects of anti-CD2 monoclonal antibodies on interleukin 2 production and interleukin 2 receptor expression in anti-CD3-induced T cell activation. Stohl W; Linker-Israeli M Cell Immunol; 1989 May; 120(2):351-65. PubMed ID: 2566387 [TBL] [Abstract][Full Text] [Related]
25. Production of granulocyte/macrophage-colony-stimulating factor by human natural killer cells. Modulation by the p75 subunit of the interleukin 2 receptor and by the CD2 receptor. Levitt LJ; Nagler A; Lee F; Abrams J; Shatsky M; Thompson D J Clin Invest; 1991 Jul; 88(1):67-75. PubMed ID: 1676038 [TBL] [Abstract][Full Text] [Related]
26. Differential CD3/T cell antigen receptor-mediated IL-2 production in jurkat T cells. Dissociation of IL-2 response from total inositol phosphate and calcium responses. Stohl W; Hofman FM; Gray JD J Immunol; 1990 Aug; 145(4):1078-87. PubMed ID: 2143206 [TBL] [Abstract][Full Text] [Related]
27. The effect of the CD28 activation pathway on the immunosuppressive action of cyclosporine. Hess AD; Bright EC Transplantation; 1991 Jun; 51(6):1232-40. PubMed ID: 1646506 [TBL] [Abstract][Full Text] [Related]
28. Activation of peripheral blood T cells via the p75 interleukin 2 receptor. Yagita H; Nakata M; Azuma A; Nitta T; Takeshita T; Sugamura K; Okumura K J Exp Med; 1989 Oct; 170(4):1445-50. PubMed ID: 2571670 [TBL] [Abstract][Full Text] [Related]
29. The induction of T cell-mediated cytolysis by monoclonal antibodies against the T cell receptor/CD3 complex. Spits H; Yssel H; de Vries JE Int Rev Immunol; 1989 May; 4(2):115-32. PubMed ID: 2577219 [No Abstract] [Full Text] [Related]
30. Cell membrane expression and functional role of the p75 subunit of interleukin-2 receptor in lymphoproliferative disease of granular lymphocytes. Zambello R; Trentin L; Pizzolo G; Bulian P; Masciarelli M; Feruglio C; Agostini C; Raimondi R; Chisesi T; Semenzato G Blood; 1990 Nov; 76(10):2080-5. PubMed ID: 2146981 [TBL] [Abstract][Full Text] [Related]
31. Anti-CD3 monoclonal antibody-mediated cytotoxicity occurs through an interleukin-2-independent pathway in CD3+ large granular lymphocytes. Loughran TP; Aprile JA; Ruscetti FW Blood; 1990 Feb; 75(4):935-40. PubMed ID: 2302461 [TBL] [Abstract][Full Text] [Related]
32. DNA fragmentation and cell death mediated by T cell antigen receptor/CD3 complex on a leukemia T cell line. Takahashi S; Maecker HT; Levy R Eur J Immunol; 1989 Oct; 19(10):1911-9. PubMed ID: 2531090 [TBL] [Abstract][Full Text] [Related]
33. The anti-T cell monoclonal antibody 9.3 (anti-CD28) provides a helper signal and bypasses the need for accessory cells in T cell activation with immobilized anti-CD3 and mitogens. Baroja ML; Lorre K; Van Vaeck F; Ceuppens JL Cell Immunol; 1989 Apr; 120(1):205-17. PubMed ID: 2539266 [TBL] [Abstract][Full Text] [Related]
34. Role in T-cell activation for HLA class I molecules from accessory cells: further distinction between activation signals delivered to T cells via CD2 and CD3 molecules. Huet S; Boumsell L; Raynal B; Degos L; Dausset J; Bernard A Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7222-6. PubMed ID: 3118361 [TBL] [Abstract][Full Text] [Related]
35. Role of T-cell antigens in the cytolytic activities of large granular lymphocytes (LGLs) in patients with LGL lymphocytosis. Oshimi K; Oshimi Y; Akahoshi M; Kobayashi Y; Hirai H; Takaku F; Hattori M; Asano S; Kodo H; Nishinarita S Blood; 1988 Feb; 71(2):473-9. PubMed ID: 2447984 [TBL] [Abstract][Full Text] [Related]
36. Generation propagation, and targeting of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus recombinant IL-2. An efficient strategy for adoptive tumor immunotherapy. Nishimura T; Nakamura Y; Takeuchi Y; Tokuda Y; Iwasawa M; Kawasaki A; Okumura K; Habu S J Immunol; 1992 Jan; 148(1):285-91. PubMed ID: 1345787 [TBL] [Abstract][Full Text] [Related]
37. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor. Bolhuis RL; Roozemond RC; van de Griend RJ J Immunol; 1986 Jun; 136(11):3939-44. PubMed ID: 3084649 [TBL] [Abstract][Full Text] [Related]
38. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69. Woods M; Guy R; Waldmann H; Glennie M; Alexander DR Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688 [TBL] [Abstract][Full Text] [Related]
39. Differential regulation of lymphokine production by distinct subunits of the T cell interleukin 2 receptor. Burdach S; Zessack N; Dilloo D; Shatsky M; Thompson D; Levitt L J Clin Invest; 1991 Jun; 87(6):2114-21. PubMed ID: 1828253 [TBL] [Abstract][Full Text] [Related]
40. Role of CD2 in regulation of CD3- LGL function. Mason A; Bernard A; Smyth MJ; Ortaldo JR Eur Cytokine Netw; 1991; 2(1):31-7. PubMed ID: 1714784 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]